Table 1. Characterization of the groups studied.
| Variables* | Group 1 | Group 2 | ||
|---|---|---|---|---|
| Total (n=65) | Unfavorable intermediate and high risk (n=38) | Total (n=91) | Unfavorable intermediate and high risk (n=51) | |
| Age, years | 66.0 (59.0-71.0) | 67.0 (61.0-71.5) | 65.0 (58.7-69.2) | 66.0 (60.7-71.2) |
| BMI, kg/m2 | 27.0 (26.0-30.7) | 27.0 (26.0-30.2) | 27.0 (25.5-30.0) | 27.0 (25.0-30.0) |
| PSA, ng/dL | 6.0 (4.5-10.0) | 6.1 (5.1-10.8) | 5.5 (3.6-8.2) | 5.9 (4.8-10.3) |
Results expressed as median and 95% confidence interval.
BMI: body mass index; PSA: prostatic specific antigen.